| Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: results from the CORONADO study B Cariou, T Goronflot, A Rimbert, S Boullu, C Le May, P Moulin, ... Diabetes & Metabolism 47 (2), 101202, 2021 | 90 | 2021 |
| Genetics of syndromic and non-syndromic mitral valve prolapse T Le Tourneau, J Mérot, A Rimbert, S Le Scouarnec, V Probst, H Le Marec, ... Heart 104 (12), 978-984, 2018 | 90 | 2018 |
| GPR146 deficiency protects against hypercholesterolemia and atherosclerosis H Yu, A Rimbert, AE Palmer, T Toyohara, Y Xia, F Xia, LMR Ferreira, ... Cell 179 (6), 1276-1288. e14, 2019 | 75 | 2019 |
| Genetics, lifestyle, and low-density lipoprotein cholesterol in young and apparently healthy women JW Balder, A Rimbert, X Zhang, M Viel, R Kanninga, F van Dijk, ... Circulation 137 (8), 820-831, 2018 | 46 | 2018 |
| Taking One Step Back in Familial Hypercholesterolemia: STAP1 Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans N Loaiza, ML Hartgers, LF Reeskamp, JW Balder, A Rimbert, V Bazioti, ... Arteriosclerosis, thrombosis, and vascular biology 40 (4), 973-985, 2020 | 42 | 2020 |
| Mendelian randomization while jointly modeling cis genetics identifies causal relationships between gene expression and lipids A van Der Graaf, A Claringbould, A Rimbert, ... Nature communications 11 (1), 4930, 2020 | 37 | 2020 |
| Phenotypic differences between polygenic and monogenic hypobetalipoproteinemia A Rimbert, X Vanhoye, D Coulibaly, M Marrec, M Pichelin, S Charrière, ... Arteriosclerosis, Thrombosis, and Vascular Biology 41 (1), e63-e71, 2021 | 33 | 2021 |
| A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein … A Rimbert, N Dalila, JC Wolters, N Huijkman, M Smit, N Kloosterhuis, ... European heart journal 41 (9), 1040-1053, 2020 | 28 | 2020 |
| Genetic inhibition of PCSK9 and liver function A Rimbert, S Smati, W Dijk, C Le May, B Cariou JAMA cardiology 6 (3), 353-354, 2021 | 26 | 2021 |
| Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia A Rimbert, M Pichelin, S Lecointe, M Marrec, S Le Scouarnec, E Barrak, ... Atherosclerosis 250, 52-56, 2016 | 21 | 2016 |
| LDL lowering effect of PCSK9 inhibition is reduced in women VA Myasoedova, A Rimbert, M Camera, C Le May, R Capoulade, ... European Heart Journal-Cardiovascular Pharmacotherapy 9 (4), 337-342, 2023 | 17 | 2023 |
| Posttranscriptional regulation of the human LDL receptor by the U2-Spliceosome P Zanoni, G Panteloglou, A Othman, JT Haas, R Meier, A Rimbert, ... Circulation research 130 (1), 80-95, 2022 | 15 | 2022 |
| PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs M Roudaut, S Idriss, A Caillaud, A Girardeau, A Rimbert, B Champon, ... Stem Cell Reports 16 (12), 2958-2972, 2021 | 15 | 2021 |
| The future of lipid-lowering therapy W Van Zwol, A Rimbert, JA Kuivenhoven Journal of Clinical Medicine 8 (7), 1085, 2019 | 15 | 2019 |
| Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia W Dijk, M Di Filippo, S Kooijman, R Van Eenige, A Rimbert, A Caillaud, ... Circulation 146 (10), 724-739, 2022 | 14 | 2022 |
| Advancements in risk stratification and management strategies in primary cardiovascular prevention F Barkas, YZ Sener, PA Golforoush, A Kheirkhah, E Rodriguez-Sanchez, ... Atherosclerosis 395, 117579, 2024 | 13 | 2024 |
| Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion W van Zwol, A Rimbert, JC Wolters, M Smit, VW Bloks, NJ Kloosterhuis, ... Hepatology (Baltimore, Md.) 78 (5), 1418, 2023 | 13 | 2023 |
| A new 165-SNP low-density lipoprotein cholesterol polygenic risk score based on next generation sequencing outperforms previously published scores in routine diagnostics of … X Vanhoye, C Bardel, A Rimbert, P Moulin, PA Rollat-Farnier, M Muntaner, ... Translational Research 255, 119-127, 2023 | 13 | 2023 |
| FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells A Caillaud, A Lévêque, A Thédrez, A Girardeau, R Canac, L Bray, ... STAR protocols 3 (4), 101680, 2022 | 12 | 2022 |
| Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans S Hendrix, J Kingma, R Ottenhoff, M Valiloo, M Svecla, LF Zijlstra, ... Nature communications 14 (1), 5181, 2023 | 10 | 2023 |